BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 16307555)

  • 1. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
    Fan SR; Liu XP
    Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
    Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
    Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, susceptibility profile and proteinase production of yeasts causing vulvovaginitis in Turkish women.
    Ozcan SK; Budak F; Yucesoy G; Susever S; Willke A
    APMIS; 2006 Feb; 114(2):139-45. PubMed ID: 16519751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
    Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
    Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined single-day treatment in acute vulvovaginal candidosis].
    Kovachev S; Nacheva A; Vacheva-Dobrevska R; Vasilev N
    Akush Ginekol (Sofiia); 2009; 48(6):18-23. PubMed ID: 20225492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z; Sobel JD
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
    Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
    Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, species distribution and antifungal sensitivity of vaginal yeasts in infertile women.
    Verghese S; Padmaja P; Asha M; Elizabeth SJ; Anitha A; Kundavi KM; Jayanthi N; Varma T
    Indian J Pathol Microbiol; 2001 Jul; 44(3):313-4. PubMed ID: 12024920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.